Wockhardt Wrexham Sterile Injectable Manufacturing Facility Expansion
Wrexham, UK · 2016-Present (ongoing expansions) · £10m (2016 sterile manufacturing facility), £20m (2024 lending facility for expansion)
The judgement call
Account-gated at launchWockhardt Wrexham's role in producing the AstraZeneca COVID-19 vaccine highlighted its critical national importance and capability in sterile pharmaceutical manufacturing. - Continuous investment, including a £10 million sterile manufacturing facility in 2016 and a £20 million lending facility for expansion in 2024, demonstrates a commitment to enhancing its production capabilities. - The partnership with Serum Life Sciences UK for vaccine manufacturing positions the facility as a key player in future vaccine supply.
Key engineering challenges
Expanding sterile injectable manufacturing capacity under stringent regulatory requirements. - Adapting facilities for rapid production of critical vaccines (e.g., during a pandemic). - Maintaining high-level aseptic conditions and quality control for sterile products. - Integrating new manufacturing lines for diverse vaccine types.
Project facts
- Client / owner
- Wockhardt UK (in partnership with Serum Life Sciences UK for vaccine production)
- Lead contractor
- —
- Lead designers
- —
- Project type
- upgrade | expansion
- Scale
- 16,000m2 sterile facility area; produces Small Volume Parenterals (SVP); crucial for AstraZeneca COVID-19 vaccine production; partnership for various vaccine manufacturing.
- Disciplines
- pharmaceutical engineering; process engineering; mechanical; electrical; civil; structural; cleanroom technology
- Standards & frameworks
- GMP (Good Manufacturing Practices), MHRA regulations
Sources: Wockhardt UK (https://www.wockhardt.co.uk/services/our-facility-in-wrexham/) - Fierce Pharma (Nov 2016, https://www.fiercepharma.com/manufacturing/wockhardt-to-invest-12-4m-uk-plant-add-up-to-50-new-jobs) - Gov.Wales (Jun 2021, https://www.gov.wales/ministers-praise-wrexham-based-wockhardt-covid-19-vaccine-success) - Business Live (Jun 2024, https://www.business-live.co.uk/manufacturing/north-wales-operation-pharma-giant-29306140) - Bioprocess International (https://www.bioprocessintl.com/facilities-capacity/wockhardt-and-serum-to-construct-plant-in-uk)